Document is current
Any future updates will be listed below
-
Authors
Maimaitili, Muyesier
Chen, Muwan https://orcid.org/0000-0001-9676-7756
Febbraro, Fabia
Ucuncu, Ekin
Kelly, Rachel https://orcid.org/0000-0003-4085-0299
Niclis, Jonathan Christos
Christiansen, Josefine Rågård https://orcid.org/0000-0001-9808-9290
Mermet-Joret, Noëmie
Niculescu, Dragos
Lauritsen, Johanne
Iannielli, Angelo
Klæstrup, Ida H.
Jensen, Uffe Birk https://orcid.org/0000-0002-6205-6355
Qvist, Per https://orcid.org/0000-0002-0750-0089
Nabavi, Sadegh https://orcid.org/0000-0002-3940-1210
Broccoli, Vania https://orcid.org/0000-0003-4050-0926
Nykjær, Anders https://orcid.org/0000-0001-6422-6736
Romero-Ramos, Marina https://orcid.org/0000-0003-0970-578X
Denham, Mark https://orcid.org/0000-0001-5279-5915
-
Funding
Funding for this research was provided by:
Lundbeckfonden (R248-2016-2518)
Danmarks Grundforskningsfond
- License Information
-
More Information
Article History
Received: 20 March 2023
Accepted: 10 November 2023
First Online: 5 December 2023
Competing interests
: M.M. and M.D. are inventors on a patent application filed by Aarhus University, WO2022136306A1 (National phase) that is related to the generation of lineage restricted cells. J.C.N. and J.R.C. are employed by Novo Nordisk. The remaining authors declare no competing interests.
